Mutation in the Bacillus subtilis RNA polymerase beta' subunit confers resistance to lipiarmycin.
作者信息
Gualtieri Maxime, Villain-Guillot Philippe, Latouche Jaqueline, Leonetti Jean-Paul, Bastide Lionel
出版信息
Antimicrob Agents Chemother. 2006 Jan;50(1):401-2. doi: 10.1128/AAC.50.1.401-402.2006.
Abstract
摘要
相似文献
1
Mutation in the Bacillus subtilis RNA polymerase beta' subunit confers resistance to lipiarmycin.枯草芽孢杆菌RNA聚合酶β'亚基的突变赋予对脂霉素的抗性。
Antimicrob Agents Chemother. 2006 Jan;50(1):401-2. doi: 10.1128/AAC.50.1.401-402.2006.
2
beta' subunit of bacterial RNA polymerase is responsible for streptolydigin resistance in Bacillus subtilis.细菌RNA聚合酶的β'亚基负责枯草芽孢杆菌对链霉溶菌素的抗性。
Nature. 1978 Apr 27;272(5656):837-9. doi: 10.1038/272837a0.
3
Streptolydigin resistance can be conferred by alterations to either the beta or beta' subunits of Bacillus subtilis RNA polymerase.枯草芽孢杆菌RNA聚合酶的β亚基或β'亚基发生改变可导致对链霉溶菌素产生抗性。
J Biol Chem. 1995 Oct 13;270(41):23930-3. doi: 10.1074/jbc.270.41.23930.
4
Anaerobic growth of Bacillus subtilis alters the spectrum of spontaneous mutations in the rpoB gene leading to rifampicin resistance.枯草芽孢杆菌的厌氧生长改变了rpoB基因中导致利福平抗性的自发突变谱。
FEMS Microbiol Lett. 2015 Dec;362(24):fnv213. doi: 10.1093/femsle/fnv213. Epub 2015 Nov 3.
5
Frequency and characterisation of spontaneous lipiarmycin-resistant Enterococcus faecalis mutants selected in vitro.体外筛选出的自发抗利皮霉素粪肠球菌突变体的频率及特性分析
Int J Antimicrob Agents. 2009 Dec;34(6):605-6. doi: 10.1016/j.ijantimicag.2009.07.003. Epub 2009 Aug 15.
6
Lipiarmycin-resistant ribonucleic acid polymerase mutants of Bacillus subtilis.枯草芽孢杆菌的抗脂臂霉素核糖核酸聚合酶突变体
J Bacteriol. 1977 Oct;132(1):73-9. doi: 10.1128/jb.132.1.73-79.1977.
7
Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.脂臂霉素作用于RNA聚合酶，对耐多药结核分枝杆菌菌株具有良好活性。
J Antimicrob Chemother. 2008 Oct;62(4):713-9. doi: 10.1093/jac/dkn269. Epub 2008 Jun 27.
8
Rapid purification of His(6)-tagged Bacillus subtilis core RNA polymerase.His(6)标签的枯草芽孢杆菌核心RNA聚合酶的快速纯化
Protein Expr Purif. 2000 Aug;19(3):350-4. doi: 10.1006/prep.2000.1272.
9
Inhibition by lipiarmycin of bacteriophage growth in Bacillus subtilis.脂霉素对枯草芽孢杆菌中噬菌体生长的抑制作用。
J Virol. 1980 Mar;33(3):945-53. doi: 10.1128/JVI.33.3.945-953.1980.
10
Uncovering new metabolic capabilities of Bacillus subtilis using phenotype profiling of rifampin-resistant rpoB mutants.利用耐利福平的rpoB突变体的表型分析揭示枯草芽孢杆菌的新代谢能力。
J Bacteriol. 2008 Feb;190(3):807-14. doi: 10.1128/JB.00901-07. Epub 2007 Jul 20.
引用本文的文献
1
Inhibition of bacterial RNA polymerase function and protein-protein interactions: a promising approach for next-generation antibacterial therapeutics.抑制细菌RNA聚合酶功能和蛋白质-蛋白质相互作用：下一代抗菌疗法的一种有前景的方法。
RSC Med Chem. 2024 Mar 26;15(5):1471-1487. doi: 10.1039/d3md00690e. eCollection 2024 May 22.
2
Biofilm Formation of , Toxin Production and Alternatives to Conventional Antibiotics in the Treatment of CDI.艰难梭菌感染治疗中生物膜形成、毒素产生及传统抗生素替代方案
Microorganisms. 2023 Aug 26;11(9):2161. doi: 10.3390/microorganisms11092161.
3
Fidaxomicin for the treatment of in children. fidaxomicin 治疗儿童。
Future Microbiol. 2020 Jul;15(11):967-979. doi: 10.2217/fmb-2020-0104. Epub 2020 Jul 27.
4
Fidaxomicin jams RNA polymerase motions needed for initiation via RbpA contacts.非达霉素阻止 RNA 聚合酶通过 RbpA 接触进行起始所需的运动。
Elife. 2018 Feb 26;7:e34823. doi: 10.7554/eLife.34823.
5
A Mutation in the Bacillus subtilis rsbU Gene That Limits RNA Synthesis during Sporulation.枯草芽孢杆菌rsbU基因中的一个突变，该突变在芽孢形成过程中限制RNA合成。
J Bacteriol. 2017 Jun 27;199(14). doi: 10.1128/JB.00212-17. Print 2017 Jul 15.
6
Antibacterials Developed to Target a Single Organism: Mechanisms and Frequencies of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compounds Fidaxomicin and LFF571.针对单一生物体开发的抗菌药物：对新型抗艰难梭菌化合物非达霉素和LFF571敏感性降低的机制及频率
Cold Spring Harb Perspect Med. 2016 Feb 1;6(2):a025445. doi: 10.1101/cshperspect.a025445.
7
Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection.非达霉素：一种治疗艰难梭菌感染的新型药物。
Can J Infect Dis Med Microbiol. 2015 Nov-Dec;26(6):305-12. doi: 10.1155/2015/934594.
8
Safety and efficacy of fidaxomicin in the treatment of Clostridium difficile-associated diarrhea. fidaxomicin 在治疗艰难梭菌相关性腹泻中的安全性和疗效。
Therap Adv Gastroenterol. 2012 Nov;5(6):395-402. doi: 10.1177/1756283X12461294.
9
New target for inhibition of bacterial RNA polymerase: 'switch region'.抑制细菌 RNA 聚合酶的新靶点：“开关区域”。
Curr Opin Microbiol. 2011 Oct;14(5):532-43. doi: 10.1016/j.mib.2011.07.030. Epub 2011 Aug 19.
10
Challenges of antibacterial discovery.抗菌药物发现的挑战。
Clin Microbiol Rev. 2011 Jan;24(1):71-109. doi: 10.1128/CMR.00030-10.
本文引用的文献
1
In vitro activities of OPT-80 and comparator drugs against intestinal bacteria.OPT-80及对照药物对肠道细菌的体外活性。
Antimicrob Agents Chemother. 2004 Dec;48(12):4898-902. doi: 10.1128/AAC.48.12.4898-4902.2004.
2
Structural basis of transcription initiation: an RNA polymerase holoenzyme-DNA complex.转录起始的结构基础：一种RNA聚合酶全酶-DNA复合物
Science. 2002 May 17;296(5571):1285-90. doi: 10.1126/science.1069595.
3
Inhibition by lipiarmycin of bacteriophage growth in Bacillus subtilis.脂霉素对枯草芽孢杆菌中噬菌体生长的抑制作用。
J Virol. 1980 Mar;33(3):945-53. doi: 10.1128/JVI.33.3.945-953.1980.
4
Tiacumicins, a novel complex of 18-membered macrolides. II. Isolation and structure determination.替考米星，一种新型的18元大环内酯类化合物。II. 分离与结构测定。
J Antibiot (Tokyo). 1987 May;40(5):575-88. doi: 10.7164/antibiotics.40.575.
5
In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile.替考米星B和C对艰难梭菌的体外和体内评价
Antimicrob Agents Chemother. 1991 Jun;35(6):1108-11. doi: 10.1128/AAC.35.6.1108.
6
Lipiarmycin: an antibiotic inhibiting nucleic acid polymerases.
Biochem Biophys Res Commun. 1975 Mar 3;63(1):328-34. doi: 10.1016/s0006-291x(75)80047-7.
7
Lipiarmycin-resistant ribonucleic acid polymerase mutants of Bacillus subtilis.枯草芽孢杆菌的抗脂臂霉素核糖核酸聚合酶突变体
J Bacteriol. 1977 Oct;132(1):73-9. doi: 10.1128/jb.132.1.73-79.1977.
Zotero 插件